Who
Christophe Jean
Director
Company insider
Files Form 4 as: Director, Rhythm Pharmaceuticals; Director, Tercica.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 13 Oct 2006
- Last trade
- 24 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,691 at $0.00 | filing |
| 24 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,691 at $0.00 | filing |
| 24 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,324 at $0.00 | filing |
| 24 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,324 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | RYTM Rhythm PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,712 | filing |
| 23 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,712 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,712 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | RYTM Rhythm PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,712 | filing |
| 24 Jun 2025filed 26 Jun 2025 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,037 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,712 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,000 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | RYTM Rhythm PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,000 | filing |
| 21 Jun 2024filed 25 Jun 2024 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 21 Jun 2024filed 25 Jun 2024 | RYTM Rhythm PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —3,000 | filing |
| 18 Jun 2024filed 20 Jun 2024 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 9 Jun 2021filed 11 Jun 2021 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.